Agonistic antibody-triggered stimulation of Angiotensin II type 1 receptor and renal allograft vascular pathology

Nephrology Dialysis Transplantation

Volumn 22, Issue 7, 2007, Pages 1819-1822

  Dragun, Duska ^a  

^a DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

Angiotensin receptors; Apheresis; Humoral immunity; Kidney transplantation; Vascular rejection

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; AUTOANTIBODY; CALCINEURIN INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIAL CELL ANTIBODY; HLA ANTIBODY; IMMUNOGLOBULIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G; LOSARTAN; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; RECEPTOR ANTIBODY; STEROID; THROMBOPLASTIN; TRANSCRIPTION FACTOR AP 1;

ANTIGEN SPECIFICITY; DIALYSIS; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC PREDISPOSITION; HUMAN; IMMUNOPATHOGENESIS; KIDNEY ALLOGRAFT REJECTION; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MOLECULAR MIMICRY; NOTE; PLASMAPHERESIS; PREECLAMPSIA; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RENAL ALLOGRAFT VASCULOPATHY; RENAL GRAFT DYSFUNCTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TARGET CELL;

ANTIBODIES; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; RECEPTOR, ANGIOTENSIN, TYPE 1; RENAL CIRCULATION; TRANSPLANTATION, HOMOLOGOUS; VASCULAR DISEASES;

EID: 34547851699     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm072     Document Type: Note

References (19)

1. Crespo M, Pascual M, Tolkoff-Rubin N et al. Acute humoral rejection in renal allograft recipients: Incidence, serology and clinical characteristics. Transplant 2001; 71: 652-658
2. Nickeleit V, Vamvakas EC, Pascual M, Poletti BJ, Colvin RB. The prognostic significance of specific arterial lesions in acute renal allograft rejection. J Am Soc Nephrol 1998; 9: 1301-1308
3. Mauiyyedi S, Crespo M, Collins AB et al. Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classfication. J Am Soc Nephrol 2002; 13: 779-787
4. Vongwiwatana A, Tasanarong A, HIdalgo LG, Halloran PF. The role of B cells and alloantibody in the host response to human organ allograft. Immunol Rev 2003; 196: 197-218
5. Böhmig G, Exner M, Habicht A et al. Capillary C4d deposition in kidney allografts: A specific marker of alloantibody-dependent graft injury. J Am Soc Nephrol 2002; 13: 1091-1099
6. Nickeleit V, Mihatsch MJ. Kidney transplants, antibodies and rejection: is C4d a magic marker? Nephrol Dial Transplant 2003; 18:2232-2239
7. Ahern AT, Artruc AB, Della Pelle P et al. Hyperacute rejection of HLA A-B identical renal allografts associated with B lymphocytes and endothelial reactive antibodies. Transplant 1982; 33: 103-105
8. Rose M. Role of MHC and non-MHC antibodies in graft rejection. Curr Opin Organ Transplant 2004; 9: 16-23
9. Praprotnik S, Blank M, Meroni PL, Rozman B, Eldor A, Shoenfeld Y. Classification of anti-endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells. Arthritis Rheum 2001; 44: 1484-1494
10. Dragun D, Müller DN, Bräsen JH et al. Angiotensin II type l-receptor activating antibodies in renal allograft rejection. N Engl J Med 2005; 352: 558-69
11. Wallukat G, Homuth V, Fischer T et al. Patients with preeclampsia develop agonisitic antibodies against the angiotensin AT1 receptor. J Clin Invest 1999; 1103: 945-952
12. Fu MI, Herlitz H, Schulze W et al. Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension. J Hypertens 2000; 18: 945-53
13. Mellor AL, Munn DH. Immunology at the maternal-fetal interface: Lessons for T cell tolerance and suppression. Annu Rev Immunol 2000; 18: 367-391
14. Heinze G, Mitterbauer C, Regele H et al. Angiotensin-converting enzyme inhibitor or angiotensin II type 1 receptor antagonist therapy is associated with prolonged patient and graft survival after renal transplantation. J Am Soc Nephrol 2006; 17: 889-899
15. 1R blockade reduces IFN-γ production in lymphocyte in vivo and in vitro. Kidney Int 2005; 67: 2134-2142
16. Slowinski T, Suker D, Schönemann C et al. Screening of patients on waiting-list for a renal transplant for agonistic non-HLA antibodies targeting angiotensin II type 1 receptor (Abstract). J Am Soc Nephrol 2006; 17: 393A
17. Nataraj C, Oliverio M, Mannon RB et al. Angiotensin II regulates cellular immune responses through calcineurin-dependent pathway. J Clin Invest 1999; 104: 1693-1701
18. Kenakin TP. Recombinant roulette versus the apparent virtues of "natural" receptor systems: Receptor genotypes vs. phenotypes. Trends Pharmacol Sci 2002; 23: 403-404
19. Yamani MH, Cook DJ, Tuzcu EM et al. Systemic up-regulation of angiotensin II type 1 receptor in cardiac donors with spontaneous intracerebral hemorrhage. Am J Transplant 2004; 4: 1907-1102